ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Durect Corp

Durect Corp (DRRX)

1.34
0.07
(5.51%)
Closed March 27 04:00PM
1.34
0.00
( 0.00% )
Pre Market: 05:59AM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1.34
Bid
1.30
Ask
1.51
Volume
18
0.00 Day's Range 0.00
0.4703 52 Week Range 7.46
Market Cap
Previous Close
1.34
Open
-
Last Trade
18
@
1.33
Last Trade Time
04:39:12
Financial Volume
-
VWAP
-
Average Volume (3m)
208,318
Shares Outstanding
29,828,891
Dividend Yield
-
PE Ratio
-1.13
Earnings Per Share (EPS)
-1.18
Revenue
19.28M
Net Profit
-35.33M

About Durect Corp

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeli... Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Durect Corp is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DRRX. The last closing price for Durect was $1.34. Over the last year, Durect shares have traded in a share price range of $ 0.4703 to $ 7.46.

Durect currently has 29,828,891 shares outstanding. The market capitalization of Durect is $39.97 million. Durect has a price to earnings ratio (PE ratio) of -1.13.

DRRX Latest News

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire CUPERTINO, Calif., March 27, 2024 - Ongoing Communication with FDA to Align...

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update PR Newswire CUPERTINO, Calif., March 20, 2024 CUPERTINO, Calif., March 20, 2024...

Form 8-K - Current report

0001082038false00010820382024-03-042024-03-04     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K   Current Report...

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZETยฎ Product Line in U.S. and Canada

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZETยฎ Product Line in U.S. and Canada PR Newswire CUPERTINO, Calif., March 4, 2024 Partnership...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c), AND...

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire CUPERTINO, Calif., Feb. 7, 2024 CUPERTINO, Calif., Feb. 7, 2024 /PRNewswire/ -- DURECT...

Form 8-K - Current report

0001082038false00010820382023-12-212023-12-21     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K   Current Report...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.097.21.251.341.151318081.27114873CS
40.356236.20654604590.98381.410.941832321.14949178CS
120.8204157.8906851420.51961.410.512083180.89622102CS
26-1.23-47.8599221792.573.140.47034992541.01001031CS
52-3.05-69.47608200464.397.460.47033479881.81706064CS
156-17.96-93.056994818719.320.50.47034941467.53387534CS
260-5.019-78.92750432466.359410.470378462115.51121162CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 17.21
(262.32%)
407.25k
BCGBinah Capital Group Inc
$ 18.50
(94.74%)
125.88k
PIKKidpik Corporation
$ 5.38
(64.53%)
1.14M
SVMHSRIVARU Holding Ltd
$ 0.3994
(50.72%)
267.36k
SSKNStrata Skin Sciences Inc
$ 0.66
(48.35%)
2
NCNANuCana PLC
$ 0.2405
(-21.57%)
31.28k
WAVDWaveDancer Inc
$ 2.93
(-18.61%)
10
MVLAMovella Holdings Inc
$ 0.0615
(-18.54%)
31.46k
UGROUrban Gro Inc
$ 1.48
(-18.46%)
393
INOInovio Pharmaceuticals Inc New
$ 10.65
(-18.27%)
33
KTRAKintara Therapeutics Inc
$ 0.1182
(32.07%)
9.96M
AKBAAkebia Therapeutics Inc
$ 2.63
(17.41%)
2.34M
GMDAGamida Cell Ltd
$ 0.0498
(-15.88%)
1.34M
CISSC3is Inc
$ 0.036
(-5.76%)
1.33M
PIKKidpik Corporation
$ 5.38
(64.53%)
1.14M

DRRX Discussion

View Posts
glenn1919 glenn1919 2 weeks ago
DRRX................................................https://stockcharts.com/h-sc/ui?s=DRRX&p=W&b=5&g=0&id=p86431144783
๐Ÿ‘๏ธ0
Swampy83 Swampy83 2 months ago
I want news!! I want $30, lol
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Can we move this today
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Thatโ€™s what these A Hoes want you to believe so you can sell at A loss MM tricks
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Owell
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 5 months ago
This pos is doneโ€ฆโ€ฆ..forget about it. I lost a lot on this one.
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Yeah something fishy going on here looks illegal to me
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
ANALYST RATING
Buy
3.00 Rating Score
UPSIDE/?DOWNSIDE
1,227.5% Upside
$34.25 Price Target
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Why not ?
๐Ÿ‘๏ธ0
DeafTrader2 DeafTrader2 5 months ago
Why ?
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Good opportunity here $$$$
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Cheapies
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
"The topline results from AHFIRM provide compelling evidence that administration of larsucosterol can reduce mortality at 90 days in this devastating disease," said James E. Brown, D.V.M., President and CEO of DURECT. "We have strong rationale to advance larsucosterol into a Phase 3 registration trial designed with adequate power to detect a statistically significant result using 90-day mortality as the primary endpoint. We look forward to meeting with the FDA to discuss next steps. Based on the strength of the clinical data generated to date, if approved, larsucosterol could save many patient lives. We extend our thanks to all the patients, families, clinical trial investigators, and staff across the multiple sites globally who have worked with the DURECT team to bring larsucosterol to this advanced stage."
๐Ÿ‘๏ธ0
INFINITI INFINITI 5 months ago
Cat bounce here got some
๐Ÿ‘๏ธ0
Youlie Youlie 10 months ago
Bullish price target.
Looking at the drug they are developing itโ€™s either home run or nothing.

๐Ÿ‘๏ธ0
Distantpulse Distantpulse 10 months ago
$44 price target. Lol

https://www.benzinga.com/quote/DRRX/analyst-ratings
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 1 year ago
100% agree. This will be a total loss for investors.
๐Ÿ‘๏ธ0
Foxwoods Man Foxwoods Man 1 year ago
There is really nothing positive about a R/S in a penny stock. It always seems to get back to the pre split price and 90% of your investment is toast. $3.60 looks better but in reality only 36 cents compared to last week
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 1 year ago
1/10 RS. 100% loss incoming. Smfh!
๐Ÿ‘๏ธ0
Jimmy Joe Jimmy Joe 1 year ago
Been not liking this company since I was told about it. They are just trying to buy time. Stick a fork in this POS.
๐Ÿ‘๏ธ0
Foxwoods Man Foxwoods Man 1 year ago
The vote is mostly just symbolic since corporate has enough votes to pass what they want.

I have NEVER seen a stock selling for under a buck do well after a R/S....it just seems to eventually get back to the pre split price and you are minus 90% of your shares.

I also voted against it
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 1 year ago
I voted against the R/S. F them!!! Hope everyone does the same. Garbageโ€ฆ..
๐Ÿ‘๏ธ0
Foxwoods Man Foxwoods Man 1 year ago
Yup....I just dumped my shares at a loss to salvage something
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 1 year ago
R/S incoming! Fโ€™in BS!!!!
๐Ÿ‘๏ธ0
Jimmy Joe Jimmy Joe 2 years ago
.how do you let your share price get this low.

When you don't have much in the pipeline and you have novice investors falling for every stupid PR you put out there. SO glad I stayed away form DRRX. Total garbage.
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 2 years ago
What a garbage companyโ€ฆโ€ฆ.how do you let your share price get this low.
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 2 years ago
How low are they gonna let this POS go?! My godโ€ฆโ€ฆSmfh.
๐Ÿ‘๏ธ0
Jimmy Joe Jimmy Joe 2 years ago
Pretty much puts everything in a nutshell. DRRX POS~!

Will be lucky to see $2 again.....

If in this play.... get out ...... or take the ride down.

Just my opinion.
๐Ÿ‘๏ธ0
Distantpulse Distantpulse 2 years ago
What a POS this stock is!! Smh
๐Ÿ‘๏ธ0
suissac suissac 3 years ago
The two big catalyst for me is: (1). The authorized share count was not increased to 600,000,000 shares, even though DRRX had the votes; that is very, very, interesting. (2) The quarterly filing was was moved up to 7/29/2021. Theses two catalyst, could pertain to a partnership or a buyout news pending. The ship is getting ready to sail, and the rocket is going to the moon. My Opinion!
๐Ÿ‘๏ธ0
suissac suissac 3 years ago
I see why the stock price is down; all the Insiders are Filing Form 4 today and receiving stock at a very low price.
๐Ÿ‘๏ธ0
JohnLocke101 JohnLocke101 3 years ago
Iโ€™ll take $3.49
๐Ÿ‘๏ธ0
mitchgree mitchgree 3 years ago
WILL NOT MOVE OVER $3.5O
๐Ÿ‘๏ธ0
Jimmy Joe Jimmy Joe 3 years ago
DRRX is going nowhere real fast. Bail and grab some $AMC.
๐Ÿ‘๏ธ0
JohnLocke101 JohnLocke101 3 years ago
Durect Price Target Announced at $6.00/Share by HC Wainwright & Co.
๐Ÿ‘๏ธ0
suissac suissac 3 years ago
DRRX: This CEO doesn't PR much.
๐Ÿ‘๏ธ0
suissac suissac 3 years ago
The hogs are now fed; now we move up!
๐Ÿ‘๏ธ0
suissac suissac 3 years ago
Three Conference's coming this March, start your engines!
๐Ÿ‘๏ธ0
vwlibra vwlibra 3 years ago
Um... maybe?

https://towardsdatascience.com/effect-of-financial-statement-release-on-stock-prices-97932b2cb05

๐Ÿ‘๏ธ0
suissac suissac 3 years ago
Will the 3/4/2021 10Q move the stock?
๐Ÿ‘๏ธ0
vwlibra vwlibra 3 years ago
I think so. I bought a small block today and intend to sit on this for a bit.
๐Ÿ‘๏ธ0
GolfFishSurf GolfFishSurf 3 years ago
8-K out yesterday, showing that the offering is done and closed. Anyone think this will start to rise now that the offering is over and done with?
๐Ÿ‘๏ธ0
stet stet 3 years ago
Got 50K somewhat derisked and looking for an upside.
๐Ÿ‘๏ธ0
RNsidersbuying RNsidersbuying 3 years ago
DURECT Corporation Announces U.S. FDA Approval of POSIMIR® For Post-Surgical Pain Reduction for up to 72 Hours Following Arthroscopic Subacromial Decompression

https://www.marketwatch.com/press-release/durect-corporation-announces-us-fda-approval-of-posimir-for-post-surgical-pain-reduction-for-up-to-72-hours-following-arthroscopic-subacromial-decompression-2021-02-02?siteid=bigcharts&dist=bigcharts&tesla=y

Any renewed interest? Anyone?
๐Ÿ‘๏ธ0
whytestocks whytestocks 4 years ago
News: $DRRX Durect Corp (DRRX) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Durect Corp   (NASDAQ: DRRX) Q2 2020 Earnings Call Aug 3, 2020 , 4:30 p.m. ET Operator Continue reading

Got this from DRRX - Durect Corp (DRRX) Q2 2020 Earnings Call Transcript
๐Ÿ‘๏ธ0
whytestocks whytestocks 4 years ago
News: $DRRX DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs

CUPERTINO, Calif. , Aug. 3, 2020 /PRNewswire/ --  DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2020 and provided a corporate update. Total revenues were $25.8 million and net income was $14.3 million for the three ...

Read the whole news DRRX - DURECT Corporation Announces Second Quarter 2020 Financial Results and Update of Programs
๐Ÿ‘๏ธ0
ClayTrader ClayTrader 4 years ago
* * $DRRX Video Chart 06-25-2020 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
ClayTrader ClayTrader 4 years ago
* * $DRRX Video Chart 05-12-2020 * *

Link to Video - click here to watch the technical chart video

๐Ÿ‘๏ธ0
Runners123 Runners123 4 years ago
NDA filed, when ever approved this will be $25 over night
๐Ÿ‘๏ธ0
Runners123 Runners123 4 years ago
Yep its a buy now
๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock